Efficacy of ipragliflozin as monotherapy or as add‐on therapy with other oral antidiabetic medications for treating type 2 diabetes in Japanese patients with inadequate glycemic control: A subgroup analysis based on patient characteristics

AIMS/INTRODUCTION: The aim of the present study was to evaluate the efficacy and safety of ipragliflozin in treating Japanese type 2 diabetes patients with inadequate glycemic control by investigating diurnal variations of blood glucose and body composition. MATERIALS AND METHODS: This was an invest...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Diabetes Investig
Hlavní autoři: Osonoi, Takeshi, Nakamoto, Shinya, Saito, Miyoko, Tamasawa, Atsuko, Ishida, Hidenori, Osonoi, Yusuke
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2017
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5835480/
https://ncbi.nlm.nih.gov/pubmed/28644562
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.12705
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky